Table 1: Comparing the mean baseline and final measurements in Group A.
Group A (n = 101) |
||||
Baseline |
Final |
|||
Clinicals |
Mean (SD) |
Mean (SD) |
Δ |
p-value |
HR, bpm |
79.56 ± 14.98 |
72.09 ± 12.29 |
-7.47 |
< 0.0000 |
Systolic BP, mmHg |
131.09 ± 20.35 |
127.62 ± 16.34 |
-3.47 |
0.0960 |
Diastolic BP, mmHg |
78.17 ± 11.86 |
72.59 ± 10.43 |
-5.58 |
0.0001 |
Weight, kg |
92.26 ± 22.35 |
90.40 ± 22.78 |
-1.86 |
0.0283 |
BMI, kg/m2 |
30.84 ± 6.28 |
30.17 ± 6.62 |
-0.67 |
0.0130 |
T. Chol, mg/dl |
166.27 ± 48.96 |
147.13 ± 35.75 |
-19.14 |
0.0002 |
Trig, mg/dl |
126.31 ± 87.10 |
112.57 ± 50.88 |
-13.74 |
0.0601 |
HDL, mg/dl |
47.59 ± 13.40 |
47.03 ± 11.09 |
-0.56 |
0.5562 |
LDL, mg/dl |
95.00 ± 44.85 |
76.97 ± 31.29 |
-18.03 |
0.0001 |
FBS, mg/dl |
120.25 ± 42.30 |
118.75 ± 41.65 |
-1.5 |
0.7674 |
HbA1c, % |
7.22 ± 1.75 |
6.85 ± 1.18 |
-0.37 |
0.1631 |
LVIDd, cm |
5.35 ± 0.74 |
4.95 ± 0.62 |
-0.4 |
< 0.0000 |
LVIDS, cm |
4.37 ± 0.93 |
3.6 ± 0.65 |
-0.77 |
< 0.0000 |
EF, % |
30.44 ± 9.05 |
51.85 ± 7.56 |
-21.41 |
< 0.0000 |